Table 2 Frequency of various articular and extra-articular manifestations, treatment regimens and laboratory abnormalities in 105 patients

Current Treatment

 Methotrexate

53

50.5

 Sulphasalazine

28

26.7

 Leflunomide

4

3.8

 Ciclosporin

1

1

 Anti-TNF

21

20

 Secukinumab

13

12.4

 Ustekinumab

7

6.7

Bone erosions on radiography

39

73.1

ESR mm/hour (Means ± SD)

32.3

± 25

CRP mg/L (Means ± SD)

10.5

± 22

Nail psoriasis

57

54.3

Monoarthritis

2

1.9

Oligoyarthritis

9

8.6

Polyarthritis

84

80

Axial

37

35.2

Enthesitis

27

25.7

Dactylitis

31

29.5

HLA-B27

 Not available

75

71.4

 Positive

26

24.8

 Negative

4

3.8

Extra-articular

 Psoriasis

95

90.5

 IBD & psoriasis

3

2.9

 Uveitis & psoriasis

3

2.9

DAPSA (Means ± SD)

32.9

± 32.7

PsAID-12 (Means ± SD)

4.55

± 2.4

HAQ (Means ± SD)

0.86

± 0.62

PHQ-4

4.04

± 3.0

FiRST suggestive of fibromylagia

31

29.5